October 8, 2016
Corruption in the Pharma Industry: Perspectives from Nigeria
Healthcare companies claim second place on the current FCPA investigation list
Lobbying the NHS
Transparency International launches new principles to promote integrity in the pharmaceutical industry in Latin America
Business Principles for Promoting Integrity in the Pharmaceutical Sector in Latin America
Corruption in the pharmaceutical sector
Sosa-Iudicissa, M., & Tejedor del Real, P. (2012) Disease Mongering (Pseudo-Disease Promotion. European Parliament.
Sismondo, S. (2013) ‘Key opinion leaders and the corruption of medical knowledge: What the Sunshine Act will and won’t cast light on’, The Journal of Law, Medicine & Ethics, 41(3), pp. 635–643.
Rose, S.L. (2013) ‘Patient advocacy organizations: Institutional conflicts of interest, trust, and Trustworthiness’, The Journal of Law, Medicine & Ethics, 41(3), pp. 680–687.
Rodwin, M.A. (2013) ‘Rooting out institutional corruption to manage inappropriate off-label drug use’, The Journal of Law, Medicine & Ethics, 41(3), pp. 654–664.